Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.

Clin Transl Gastroenterol · 2019 · PMC6708662 · PMID 31356481

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

just failed to reach significanceP = 0.06so close (0.05 < p ≤ 0.1)

The mean value of the anti-CdtB biomarker was higher in the IBS vs healthy control group, but this just failed to reach significance ( P = 0.06).

also in 279 other papers

borderline significantno p-value reported

Notably, we did find anti-CdtB discriminated Rome III FD and IBS/FD overlap from health and this was borderline significant in IBS.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.